Fred Guerard, Pharm.D. joins Qlaris as President and Chief Executive Officer. Dr. Guerard brings more than two decades of global leadership experience in ophthalmology and biotechnology, with a track record of advancing innovative therapies through late-stage development and toward commercialization. Dr. Guerard most recently served as CEO of Opthea, where he strengthened the company’s strategic […]
Archives for Board of DirectorsPublications & Posters
VIEW:
The below publications outline research from Qlaris Bio's initial formulation, QLS-101. Based on this research, we have now developed a new formulation of our program, called QLS-111.